Ann: Trading Halt, page-14

Hey Clyde,
Yeah I certainly feel your frustration, it has been for me plenty of times, but I conceded a few years ago that I got in to this stock a little early, so there's been some opportunity cost for me personally in comparison to other stocks that I could have invested the money in. I do still believe the company is on a much more certain path now than what it was as an R&D shop, yes it still carries risks but as you can see from the latest report, the firm order book is now up to $130m out to 2019, we now have 2.5m approx in the bank and are cash flow positive. Debt is around 16m of around 18m in facilities available (if ive read the report correctly) so getting some of that down would be nice, which they've started to do with the 500k payment from cash flow in the last quarter. Some of this CR could be shared between working capital requirements and paying down some more of that debt, so will be interesting to see what their intentions are for the new capital.
Cheers...